Beta-adrenergic blocking drugs may exacerbate vitiligo.
Schallreuter
K U
KU
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012880:Skin Pigmentation / Q000187:drug effects; D014820:Vitiligo / Q000139:chemically induced*
D000319:Adrenergic beta-Antagonists